Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Retained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Abivax (AAVXF) Non-Current Debt (2022 - 2025)

Historic Non-Current Debt for Abivax (AAVXF) over the last 4 years, with Q3 2025 value amounting to $4.9 million.

  • Abivax's Non-Current Debt changed N/A to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year change of. This contributed to the annual value of $25.0 million for FY2024, which is 4184.32% down from last year.
  • As of Q3 2025, Abivax's Non-Current Debt stood at $4.9 million.
  • In the past 5 years, Abivax's Non-Current Debt registered a high of $42.7 million during Q4 2023, and its lowest value of $4.9 million during Q3 2025.
  • Over the past 4 years, Abivax's median Non-Current Debt value was $25.1 million (recorded in 2025), while the average stood at $24.0 million.
  • In the last 5 years, Abivax's Non-Current Debt skyrocketed by 15776.71% in 2023 and then plummeted by 4153.09% in 2024.
  • Abivax's Non-Current Debt (Quarter) stood at $16.6 million in 2022, then surged by 157.77% to $42.7 million in 2023, then plummeted by 41.53% to $25.0 million in 2024, then plummeted by 80.48% to $4.9 million in 2025.
  • Its Non-Current Debt was $4.9 million in Q3 2025, compared to $27.4 million in Q2 2025 and $25.1 million in Q1 2025.